Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly

Erik Ingelsson1, Lars Lind

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. erik.ingelsson@ki.se

Diabetes Care
|December 31, 2008
PubMed

Insights

Serum retinol-binding protein 4 (RBP4) was inversely associated with carotid artery intima-media and plaque echogenicity. These findings suggest RBP4 may play a role in atherosclerosis development.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Gerontology

Background:

  • Subclinical cardiovascular disease (CVD) is a precursor to overt cardiovascular events.
  • Retinol-binding protein 4 (RBP4) is an adipokine with potential roles in metabolic and cardiovascular health.

Purpose of the Study:

  • To investigate the association between serum RBP4 concentrations and markers of subclinical CVD.

Main Methods:

  • The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study included 1,008 participants aged 70 years.
  • Subclinical CVD was assessed using echocardiography, carotid artery ultrasound, brachial artery ultrasound, and forearm endothelial vasoreactivity.
  • Serum RBP4 levels were measured and analyzed in relation to CVD markers.

Main Results:

  • Serum RBP4 concentrations showed an inverse association with carotid artery intima-media echogenicity (beta -0.39, 95% CI -0.55 to -0.22).
  • An inverse association was also observed between RBP4 and carotid artery plaque echogenicity (beta -0.33, 95% CI -0.60 to -0.05).
  • These associations remained significant after adjusting for multiple CVD risk factors.

Conclusions:

  • Circulating RBP4 levels are inversely correlated with carotid artery intima-media and plaque echogenicity.
  • These findings suggest a potential role for RBP4 in the pathogenesis of atherosclerosis.
  • Further research is warranted to elucidate the precise mechanisms linking RBP4 to atherosclerotic processes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...